Rahul Sarugaser

Stock Analyst at Raymond James

(0.01)
# 4,520
Out of 4,918 analysts
10
Total ratings
12.5%
Success rate
-27.99%
Average return

Stocks Rated by Rahul Sarugaser

Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $0.99
Upside: +203.03%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $2.31
Upside: +332.90%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $100
Current: $12.19
Upside: +720.34%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $5.50
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11$2.5
Current: $1.54
Upside: +62.34%